C12N 2760/18851
Methods of production or purification of viral material
C12N2760/18851 (Methods of production or purification of viral material) appears on 14 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 16
- Assignees
- 13
- Inventors
- 40
- Latest grant
- 24 Apr 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 3 |
| 2003 | 1 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for transient expression of recombinant RNA24 Apr 2018US 9,951,349 B2Yale University
- Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells6 Sep 2011US 8,012,749 B2Genomidea Inc.
- Recombinant sendai virus28 Oct 2008US 7,442,544 B2DNAVEC Research Inc.
- Recombinant Sendai virus5 Sep 2006US 7,101,685 B2DNAVEC Research Inc.
- Negative strand RNA viral vector having autonomous replication capability20 Apr 2004US 6,723,532 B2DNAVEC Research Inc.
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector27 Aug 2026US 2026/0250709 A1Repli-Tech Co., Ltd.
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector19 Sep 2024US 2024/0309335 A1Repli-Tech Co., Ltd.
- Retroviral vectors14 Mar 2024US 2024/0082327 A1
- Method for expression of heterologous proteins using a recombinant negative-strand rna virus vector14 May 2015US 2015/0133531 A1Amvac AG
- Compositions and Methods for Transient Expression of Recombinant RNA4 Sep 2014US 2014/0249212 A1Yale University
Most cited
By later US patents
- Antiviral agents73US 4,859,769 ASymbicom AB · 1989
- Fibrin gel-containing filter of porous material15US 4,505,817 ANew York Blood Center, Inc. · 1985
- Antiviral agents15US 4,980,462 ASymbicom Aktiebolag · 1990
- Fibrin gel14US 4,587,018 ANew York Blood Center, Inc. · 1986
- Fibrin gel-containing filter13US 4,640,778 ANew York Blood Center, Inc. · 1987